Scientists reported a 51-year-old female with murine double minute 2(MDM2)-amplified, TP53-wild type adenoid cystic carcinoma who was treated with a MDM2 inhibitor and developed persistent pancytopenia despite drug discontinuation.
[NPJ Precision Oncology]